longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CLX

CLX
----

LongbridgeAI

This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

benzinga_article
Jul 28, 2026 at 12:12 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Wall Street analysts downgraded five stocks on Tuesday: Levi Strauss (LEVI) by Wells Fargo, Selective Insurance (SIGI) by BMO, Alpine Income Property Trust (PINE) by Raymond James, Clorox (CLX) by Jefferies, and Progyny (PGNY) by Barclays. Most maintained or adjusted price targets while lowering ratings from bullish to neutral or hold.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Wells Fargo analyst Ike Boruchow downgraded Levi Strauss & Co (NYSE:LEVI) from Overweight to Equal-Weight and maintained the price target of $25. Levi Strauss shares closed at $25.53 on Monday. See how other analysts view this stock.
  • BMO Capital analyst Michael Zaremski downgraded Selective Insurance Group Inc (NASDAQ:SIGI) from Outperform to Market Perform and maintained the price target of $97. Selective Insurance closed at $92.78 on Monday. See how other analysts view this stock.
  • Raymond James analyst RJ Milligan downgraded Alpine Income Property Trust Inc (NYSE:PINE) from Strong Buy to Outperform and maintained the price target of $22. Alpine Income Property shares closed at $20.64 on Monday. See how other analysts view this stock.
  • Jefferies analyst Kaumil Gajrawala downgraded Clorox Co (NYSE:CLX) from Buy to Hold and cut the price target from $125 to $98. Clorox shares closed at $97.41 on Monday. See how other analysts view this stock.
  • Barclays analyst Peter Warendorf downgraded Progyny Inc (NASDAQ:PGNY) from Overweight to Equal-Weight and raised the price target from $27 to $34. Progyny shares closed at $31.59 on Monday. See how other analysts view this stock.

Considering buying CLX stock? Here’s what analysts think:

Photo via Shutterstock

Login to unlock999characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Progyny

Progyny

USPGNY

-0.15%

Levi Strauss

Levi Strauss

USLEVI

-1.13%

Selective Insurance

Selective Insurance

USSIGI

+0.49%